BIG PHARMA WATCH: NEW ANALYSIS FINDS BIG PHARMA REAPS BIG MULTIPLES FROM MEDICARE SPENDING ON TOP DRUGS
Part D Spending on 10 Most Popular Medications Over Five Years Averages Five Times What Drug Companies Claim to Invest in R&D In case you missed it, AARP’s Public Policy Institute released a new analysis Wednesday examining Medicare Part D spending over a year five year period, from 2016 to 2020, on the 10 top-selling brand name